Microbiome in Lung Cancer and Other Malignancies

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

September 23, 2019

Study Completion Date

May 9, 2022

Conditions
Lung CancerCancerMalignancy
Interventions
PROCEDURE

Nasal Swab

The swab is removed from packaging, moistened with sterile water if needed to prevent any discomfort to the participant. The swab is gently inserted less than one inch into the anterior nare (nostril) until resistance is met at turbinate. Then it is rotated several times against nasal wall and repeated in other nostril using the same swab.

PROCEDURE

Oral Swab

The swab is removed from packaging, moistened with sterile water if needed to prevent any discomfort to the participant. The swab is gently rubbed along the inside of the participant's cheek for 5-10 seconds.

OTHER

Stool Collection

A stool collection kit will be sent home with each participant. It will include instructions on how to collect the stool specimen and how to return the kit.

GENETIC

Microbiome analysis

Study of microbial communities found in and on the human body.

GENETIC

DNA Banking

Secure, long term storage of an individual's genetic material.

PROCEDURE

Skin Swab

Gentle rubbing of the swab will be applied to the skin on the dorsal part of the hand.

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

Sponsors
All Listed Sponsors
collaborator

Holden Comprehensive Cancer Center

OTHER

collaborator

Iowa Institute of Human Genetics

UNKNOWN

lead

Taher Abu Hejleh

OTHER

NCT03688347 - Microbiome in Lung Cancer and Other Malignancies | Biotech Hunter | Biotech Hunter